The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
FOLFOXIRI plus bevacizumab (bev) versus FOLFIRI plus bev as first-line treatment of metastatic colorectal cancer (mCRC): Updated survival results of the phase III TRIBE trial by the GONO group.
 
Chiara Cremolini
Consulting or Advisory Role - Bayer; Roche
Speakers' Bureau - Bayer
 
Fotios Loupakis
Consulting or Advisory Role - Amgen; Sanofi
Speakers' Bureau - Amgen; Bayer; Roche; Sanofi
Research Funding - Merck Serono; Roche
 
Gianluca Masi
Speakers' Bureau - Amgen; Bayer; Merck Serono; Roche
 
Vittorina Zagonel
Consulting or Advisory Role - Bayer; Roche
Speakers' Bureau - Amgen; Bayer; Merck Serono; Roche; Sanofi
 
Francesca Bergamo
No Relationships to Disclose
 
Lisa Salvatore
No Relationships to Disclose
 
Enrico Cortesi
Consulting or Advisory Role - Amgen; Merck; Roche
Speakers' Bureau - Merck Serono; Roche; Sanofi
Research Funding - Ipsen; Merck Serono; Novartis
 
Gianluca Tomasello
Consulting or Advisory Role - Amgen; Merck; Roche; Sanofi
Speakers' Bureau - Bayer; Roche
 
Monica Ronzoni
Speakers' Bureau - Merck Serono
 
Francesco Pinta
No Relationships to Disclose
 
Alberto Zaniboni
Consulting or Advisory Role - Amgen; Bayer; Celgene; Merck Serono; Roche
 
Giuseppe Tonini
Consulting or Advisory Role - Amgen; Italfarmaco; Roche; Sanofi
 
Angela Buonadonna
Speakers' Bureau - Roche
 
Domenico Amoroso
Consulting or Advisory Role - Roche
 
Claudia Sonaglio
No Relationships to Disclose
 
Alfonso De Stefano
No Relationships to Disclose
 
Corrado Boni
Consulting or Advisory Role - Amgen; Bayer; Italfarmaco; Lilly
Speakers' Bureau - GlaxoSmithKline; Merck Serono; Roche
 
Giacomo Allegrini
No Relationships to Disclose
 
Luca Boni
Research Funding - Amgen (Inst)
Patents, Royalties, Other Intellectual Property - International Patent nr. PCT/EP2012/065661
 
Alfredo Falcone
Consulting or Advisory Role - Amgen; Bayer; Merck Serono; Roche; Sanofi
Speakers' Bureau - Amgen; Bayer; Merck Serono; Roche; Sanofi
Research Funding - Amgen; Merck; Roche